Open AccessRemdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants
Author(s) -
Jared Pitts,
Jiani Li,
Jason K. Perry,
Venice Du Pont,
Nicholas C. Riola,
Lauren Rodriguez,
Xianghan Lu,
Chaitanya Kurhade,
Xuping Xie,
Grégory Camus,
Savrina Manhas,
Ross Martin,
Pei–Yong Shi,
Tomáš Cihlář,
Danielle Porter,
Hongmei Mo,
Evguenia Maiorova,
John P. Bilello
Publication year - 2022
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00222-22
Subject(s) - virology , biology , nucleoside , recombinant dna , virus , nucleoprotein , rna , nucleoside analogue , gene , genetics